Exodus Point Capital Management, LP Novo Cure LTD Transaction History

Exodus Point Capital Management, LP

$14.7 Billion
Q2 2024

A detailed history of Exodus Point Capital Management, LP transactions in Novo Cure LTD stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 76,305 shares of NVCR stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

76,305

Previous 232,711 67.21%

Holding current value

$1.12 Million

Previous $3.64 Million 64.06%

% of portfolio

0.01%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$11.83 - $24.05 $1.85 Million - $3.76 Million	-156,406 Reduced 67.21%	76,305 $1.31 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $1.03 Million - $1.43 Million	82,583 Added 55.01%	232,711 $3.64 Million
Q3 2023 Nov 09, 2023	BUY	$16.15 - $42.35 $2.24 Million - $5.87 Million	138,666 Added 1209.79%	150,128 $2.43 Million
Q2 2023 Aug 10, 2023	BUY	$40.29 - $82.51 $461,803 - $945,729	11,462 New	11,462 $476,000
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $2.26 Million - $2.98 Million	-33,303 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$56.6 - $89.9 $1.88 Million - $2.99 Million	33,303 New	33,303 $2.32 Million
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $1.14 Million - $1.6 Million	-18,975 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$75.08 - $121.99 $736,985 - $1.2 Million	9,816 Added 107.17%	18,975 $1.43 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $491,863 - $823,724	4,234 Added 85.97%	9,159 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $642,220 - $1.11 Million	4,925 New	4,925 $1.09 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $3.61 Million - $5.53 Million	-29,054 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $3.18 Million - $4.93 Million	-28,335 Reduced 49.37%	29,054 $5.03 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $779,611 - $1.49 Million	-13,430 Reduced 18.96%	57,389 $6.39 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $2.96 Million - $3.84 Million	51,663 Added 269.7%	70,819 $4.2 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $1.08 Million - $1.81 Million	-18,903 Reduced 49.67%	19,156 $1.29 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $1.99 Million - $2.74 Million	29,202 Added 329.71%	38,059 $3.21 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $547,894 - $866,214	8,857 New	8,857 $662,000

Others Institutions Holding NVCR

# of Institutions

272

Shares Held

77.1M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.54B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Novo Cure LTD Transaction History